• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Ishares Iv PLC ISHARES NASDAQ US BIOTEC UCITS USD (ACC) (BTEC)

Sell: $10.66|Buy: $10.675|Change: 0.07 (0.64%)

Open 

$10.505

Previous close 

$10.60

Trade high 

$10.725

Income frequency 

-

Year low 

$6.726

Year high 

$10.796

Replication method 

Physical Full

Volume 

164,772

Type 

ETF

UCITS 

Yes

Dividend yield 

–

Ongoing charge 

0.35

ISIN 

IE00BYXG2H39

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Before investing please read:

Key Information Document (KID/KIID)/Product Summary

Share price

Asset allocation

Top 10 holdings

Holdings 20/08/2026% of assets
Amgen Inc8.62
Vertex Pharmaceuticals Inc8.12
Gilead Sciences Inc7.18
Regeneron Pharmaceuticals Inc5.47
Moderna Inc3.40
Revolution Medicines Inc Ordinary Shares2.89
Illumina Inc2.07
Biogen Inc2.03
Alnylam Pharmaceuticals Inc1.97
argenx SE ADR1.84

Performance 31/07/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

Total return (%)
Fund+ 0.64
Category-
More...

Investment objective

The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.

Sustainability Label

This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.

Asset class

ETF

Morningstar ratingTM

Morningstar sustainability ratingTM

Morningstar Medalist RatingTM

  Morningstar analyst document

  Morningstar report document

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.